Wanting more shooters, Bulls make Isaiah Canaan signing official

SHARE Wanting more shooters, Bulls make Isaiah Canaan signing official
canaan11.jpg

The Bulls continued to all but finalize their fall camp roster, making the Isaiah Canaan signing official on Wednesday afternoon.

The two-year deal was reported last week, but with most of the front office in Las Vegas for Summer League there was a delay in the process.

“We are excited to add Isaiah to our group,’’ Bulls general manager Gar Forman said in a statement. “We feel his ability to knock down perimeter shots will be an asset to our team.’’

It will be more than just that. It will be welcomed with open arms.

A big reason that coach Fred Hoiberg had to scrap a lot of what he wanted to do offensively last season was because it’s a system that doesn’t do well with isolation players, and outside shooting is required.

The Bulls already added to the backcourt with Dwyane Wade and Rajon Rondo this summer, but Wade is a career 28-percent shooter from long range, while Rondo is at 29 percent. That’s another reason why Nikola Mirotic could get the starting nod over Taj Gibson, as Hoiberg is looking for outside shooting.

Last season with the 76ers, Canaan launched 485 threes (11th most in the league), making 176 of them (36 percent) on his way to averaging 11 points per game.

Drafted 34th overall out of Murray State back in 2013, the 25-year-old has played for both Houston and Philadelphia, starting 39 games for the 76ers last season. He can also play either guard spot off the bench.

The Latest
“It’s a real serious accusation, and I’m aware of that,” Shannon, who will stand trial on June 10 in Kansas, said at the NBA Draft Combine in the South Loop.
Luisette Kraal, a native of Curaçao, lives in the U.S. on a religious visa that has run out. For two years she has been a key figure in helping newcomers adjust to the city.
Chicago’s Jewish community was set to kick of the event at noon to celebrate Israel declaring its independence 76 years ago on May 14, 1948.
In early 2020, the FDA discussed algorithms that could operate without human oversight. Shortly afterwards, radiology professionals warned regulators in a letter that they “strongly believe it is premature for the FDA to consider approval or clearance” of such systems.